Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Nxera Pharma - Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026
GlobeNewswire

Tokyo, Japan and Cambridge, UK, 7 August 2026 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the second quarter ended 30…

chron.com - Atyr Pharma: Q2 Earnings Snapshot
Atyr Pharma: Q2 Earnings Snapshot
Chron

SAN DIEGO (AP) — SAN DIEGO (AP) — Atyr Pharma Inc. (ATYR) on Friday reported a loss of $10.3 million in its second quarter. On a per-share basis, the San Diego-based company said it had a loss of 11 cents. In the final minutes of…

seekingalpha.com - Dulan Lokuwithana - NRx Pharma rises on FDA review of ketamine ANDA (NRXP:NASDAQ)
NRx Pharma rises on FDA review of ketamine ANDA (NRXP:NASDAQ)
Seeking Alpha

Shares of NRx Pharmaceuticals (NRXP) rose on Friday after the company announced that the FDA didn't identify any major deficiencies as part of an initial review of its marketing application for its preservative-free ketamine product. The regulator…

thehindu.com - Rajulapudi Srinivas - USFDA, DCA discuss ways to boost pharma manufacturing and drug quality in Andhra Pradesh
USFDA, DCA discuss ways to boost pharma manufacturing and drug quality in Andhra Pradesh
The Hindu

The officials of the Drug Control Administration (DCA) in Andhra Pradesh and U.S. Food and Drug Administration (USFDA) discussed ways to strengthen global regulatory collaboration and promote scientific pharmaceutical manufacturing at the…

siliconrepublic.com - Laura Varley - Rinn Pharma & Biopharma to join NordicPharmaTrain network
Rinn Pharma & Biopharma to join NordicPharmaTrain network
Silicon Republic

The partnership will significantly strengthen Ireland's position within the European pharmaceutical research and innovation space. Research Ireland's Rinn Pharma & Biopharma, which is Ireland's national centre for research and innovation in the…

thehindubusinessline.com - Medical device start-ups finding it challenging to sell their products, need industry partnerships to survive: Pharma Secretary Manoj Joshi
Medical device start-ups finding it challenging to sell their products, need industry partnerships to survive: Pharma Secretary Manoj Joshi
BusinessLine

Calling India's medical device start-up ecosystem vibrant but commercially fragile, Pharma Secretary Manoj Joshi on Friday said many start-ups are struggling to take their innovations to market despite receiving government support, and urged…

pehub.com - John R Fischer - Wise Equity inks agreement to acquire E-Pharma Trento
Wise Equity inks agreement to acquire E-Pharma Trento
PE Hub

A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email:.

marketbeat.com - Q3 EPS Estimates for Urogen Pharma Lifted by HC Wainwright
Q3 EPS Estimates for Urogen Pharma Lifted by HC Wainwright
MarketBeat

3 Bullish Biotech Stocks With Explosive Growth Trends Urogen Pharma (NASDAQ:URGN - Free Report) - Investment analysts at HC Wainwright upped their Q3 2027 earnings estimates for Urogen Pharma in a research note issued to investors on Thursday…

marketbeat.com - Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Time to Buy?
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Time to Buy?
MarketBeat

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) gapped up prior to trading on Friday. The stock had previously closed at $16.85, but opened at $18.49. Ascentage Pharma Group International shares last traded at…

marketbeat.com - JPMorgan Chase & Co. Issues Positive Forecast for Royalty Pharma (NASDAQ:RPRX) Stock Price
JPMorgan Chase & Co. Issues Positive Forecast for Royalty Pharma (NASDAQ:RPRX) Stock Price
MarketBeat

Royalty Pharma (NASDAQ:RPRX - Get Free Report) had its price target upped by stock analysts at JPMorgan Chase & Co. from $58.00 to $62.00 in a note issued to investors on Friday, Benzinga reports. The brokerage currently has an 'overweight' rating…

seekingalpha.com - SA Transcript Insights Editor - Ziff Davis expects Q3 revenue down low- to mid-single digits as AI-authored code targets nearly all by end of 2026 (NASDAQ:ZD)
Ziff Davis expects Q3 revenue down low- to mid-single digits as AI-authored code targets nearly all by end of 2026 (NASDAQ:ZD)
Seeking Alpha

Proceeds will fund tax payments (about $200 million), repay $149 million convertible debt, support ongoing share buybacks, and may be used for potential M&A opportunities. Key risks include declining search referral traffic, increased use of…

marketbeat.com - Equities Analysts Offer Predictions for NAMS FY2027 Earnings
Equities Analysts Offer Predictions for NAMS FY2027 Earnings
MarketBeat

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) - Equities research analysts at HC Wainwright lowered their FY2027 earnings per share (EPS) estimates for shares of NewAmsterdam Pharma in a research note issued to investors on Thursday…

thehindu.com - The Hindu Bureau - Center's startup scheme is a boon for youngsters: CII Chairman Krishna Mohan
Center's startup scheme is a boon for youngsters: CII Chairman Krishna Mohan
The Hindu

Confederation of Indian Industries-Visakhapatnam Chairman G.Krishna Mohan on Friday that the Union government's Startup India Seed Fund Scheme would help youngsters to launch their own Startups and implement their innovation ideas very quickly.

cnbc.com - Tobias Burns - Shares of this digital medical platform were up more than 100% at one point. Here's what's driving it
Shares of this digital medical platform were up more than 100% at one point. Here's what's driving it
CNBC

Doximity had a solid first quarter and raised its full year revenue guidance. But AI search isn't baked into these forecasts, analysts believe, and it's bringing in 10 times the revenue it costs to run, the CEO revealed on the conference call. The…

fool.com - Motley Fool Transcribing - Fortrea (FTRE) Q2 2026 Earnings Call Transcript
Fortrea (FTRE) Q2 2026 Earnings Call Transcript
The Motley Fool

Wednesday, July 29, 2026 at 8 a.m. ET Chief Executive Officer - Anshul Thakral Interim Chief Financial Officer - David Smith Senior Vice President, Investor Relations - Tracy Krumme Former Chief Financial Officer - Jill McConnell Revenue -- $678.2…

Receive a Daily briefing on Pharma Industry News

Get Started